156 related articles for article (PubMed ID: 6334193)
1. [Prostatic cytoplasmic androgen receptor in prostatic disease. II. Correlation between clinical response to hormonal therapy and change of R1881 receptor content in prostatic cancer during antiandrogenic therapy].
Kitano T
Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1098-108. PubMed ID: 6334193
[No Abstract] [Full Text] [Related]
2. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor assays in advanced prostatic cancer.
Buttyan R; Olsson CA
Urol Clin North Am; 1984 May; 11(2):311-7. PubMed ID: 6375068
[TBL] [Abstract][Full Text] [Related]
4. [Prostatic cytoplasmic androgen receptor in prostatic disease. I. Serum androgen levels, cytoplasmic androgen levels and cytoplasmic R1881 receptor in prostatic disease].
Kitano T
Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1084-97. PubMed ID: 6334192
[No Abstract] [Full Text] [Related]
5. Androgen receptor content of the normal and hyperplastic canine prostate.
Shain SA; Boesel RW
J Clin Invest; 1978 Mar; 61(3):654-60. PubMed ID: 76635
[TBL] [Abstract][Full Text] [Related]
6. [Cytoplasmic androgen and estrogen receptor content in the tissues of human prostatic cancer].
Kushlinskiĭ NE; Bassalyk LS; Matveeva BP; Gorilovskiĭ LM; Degtiar' VG
Urol Nefrol (Mosk); 1984; (4):41-6. PubMed ID: 6474626
[No Abstract] [Full Text] [Related]
7. [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].
Habib FK; Chisholm GD
Arch Esp Urol; 1984 Dec; 37 Suppl 2():751-9. PubMed ID: 6085672
[No Abstract] [Full Text] [Related]
8. The role of estrogen, androgen and progestogen receptors in the management of carcinoma of the prostate.
Young JD; Sidh SM; Bashirelahi N
Trans Am Assoc Genitourin Surg; 1979; 71():23-5. PubMed ID: 545809
[TBL] [Abstract][Full Text] [Related]
9. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
Barrack ER; Bujnovszky P; Walsh PC
Cancer Res; 1983 Mar; 43(3):1107-16. PubMed ID: 6186370
[TBL] [Abstract][Full Text] [Related]
10. The binding of a potent synthetic androgen--methyltrienolone (R 1881)--to cytosol preparations of human prostatic cancer.
Walsh PC; Greco JM; Tananis CE; Hicks LL; McLoughlin MG; Menon M
Trans Am Assoc Genitourin Surg; 1977; 69():78-80. PubMed ID: 84428
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications and value of receptor levels in treatment of prostate cancer.
Connolly JG; Mobbs BG
Prostate; 1984; 5(5):477-83. PubMed ID: 6384975
[TBL] [Abstract][Full Text] [Related]
12. Correlation between clinical response to hormone therapy and steroid receptor content in prostatic cancer.
Gustafsson JA; Ekman P; Snochowski M; Zetterberg A; Pousette A; Högberg B
Cancer Res; 1978 Nov; 38(11 Pt 2):4345-8. PubMed ID: 698975
[TBL] [Abstract][Full Text] [Related]
13. Exchange assay for androgen receptors in the presence of molybdate.
Carroll SL; Rowley DR; Chang CH; Tindall DJ
J Steroid Biochem; 1984 Oct; 21(4):353-9. PubMed ID: 6387280
[TBL] [Abstract][Full Text] [Related]
14. [Predictive value of the determination of receptors in carcinoma of the prostate].
Castellanos JM; Galán A; Calvo MA; Schwartz S
Rev Esp Oncol; 1984; 31(2):265-77. PubMed ID: 6085864
[TBL] [Abstract][Full Text] [Related]
15. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
[No Abstract] [Full Text] [Related]
16. Androgen cytosol binding during compensatory overload-induced skeletal muscle hypertrophy.
Hickson RC; Kurowski TT; Galassi TM; Daniels DG; Chatterton RJ
Can J Biochem Cell Biol; 1985 May; 63(5):348-54. PubMed ID: 3874677
[TBL] [Abstract][Full Text] [Related]
17. [A study of correlations between therapeutic efficacy of anti-androgen therapy in prostatic cancer and androgen receptor content of prostatic cancer tissue].
Ohno K; Umehara T; Kumamoto Y
Nihon Hinyokika Gakkai Zasshi; 1984 Aug; 75(8):1212-24. PubMed ID: 6513222
[No Abstract] [Full Text] [Related]
18. [Importance of determining steroid hormone receptors and the treatment of prostatic cancer].
Fedotov IA; Denisov LE; Kozlov VP; Degtiar' VG
Urol Nefrol (Mosk); 1983; (1):63-70. PubMed ID: 6187115
[No Abstract] [Full Text] [Related]
19. Androgen modulation of prostate cancer cell androgen receptor content is cell line specific.
Lin AL; Shain SA
Mol Cell Endocrinol; 1989 May; 63(1-2):75-83. PubMed ID: 2787764
[TBL] [Abstract][Full Text] [Related]
20. Human prostate androgen receptor quantitation: effects of temperature on assay parameters.
Shain SA; Gorelic LS; Boesel RW; Radwin HM; Lamm DL
Cancer Res; 1982 Nov; 42(11):4849-54. PubMed ID: 6982098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
